Clinical Trials Logo
  1. Home
  2. Sexual Arousal Disorder
  3. NCT00425256

Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

Sexual Arousal Disorder Clinical Trial

Clinical Trial Summary

This 8 week at home study is designed to explore efficacy endpoints and evaluate the safety of intranasal Bremelanotide in women with Female Sexual Arousal Disorder. Efficacy will be assessed vs. a parallel placebo group.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00425256
Study type Interventional
Source Palatin Technologies
Contact
Status Completed
Phase Phase 2
Start date February 2006
Completion date May 2007
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05039775 - Clitoral Therapy Device in Alleviating Sexual Dysfunction After Genital Mutilation. N/A
Completed NCT02570282 - Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder Phase 2
Recruiting NCT05765487 - Using Thermography to Assess the Affects of Sildenafil Cream, 3.6% Phase 1
Not yet recruiting NCT02059798 - Urinary and Sexual Function Before and After Surgical Decompression of Cervical Myelopathy N/A
Completed NCT04566783 - Identification of Etiopathological and Clinical Factors in Persistent Genital Arousal Disorder
Completed NCT03592121 - Study to Investigate the Effect of AB-101 in Breast Cancer Survivors Early Phase 1
Completed NCT00746967 - An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder Phase 2
Completed NCT03720743 - Effect of Biodanza on Desire, Excitation and Sexual Inhibition N/A
Completed NCT04673708 - H - Test Usage in Identification of Sexual Orientation Among People. N/A